Accuray Incorporated Stock Fundamentals
| ARAY Stock | USD 1.83 0.09 5.17% |
Accuray Incorporated fundamentals help investors to digest information that contributes to Accuray Incorporated's financial success or failures. It also enables traders to predict the movement of Accuray Stock. The fundamental analysis module provides a way to measure Accuray Incorporated's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Accuray Incorporated stock.
Accuray |
Accuray Incorporated Company Current Valuation Analysis
Accuray Incorporated's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Accuray Incorporated Current Valuation | 338.06 M |
Most of Accuray Incorporated's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Accuray Incorporated is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Accuray Incorporated has a Current Valuation of 338.06 M. This is 97.65% lower than that of the Health Care Equipment & Supplies sector and 97.28% lower than that of the Health Care industry. The current valuation for all United States stocks is 97.97% higher than that of the company.
Accuray Incorporated Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Accuray Incorporated's current stock value. Our valuation model uses many indicators to compare Accuray Incorporated value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Accuray Incorporated competition to find correlations between indicators driving Accuray Incorporated's intrinsic value. More Info.Accuray Incorporated is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Accuray Incorporated's earnings, one of the primary drivers of an investment's value.Accuray Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Accuray Incorporated's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Accuray Incorporated could also be used in its relative valuation, which is a method of valuing Accuray Incorporated by comparing valuation metrics of similar companies.Accuray Incorporated is currently under evaluation in current valuation category among its peers.
Accuray Fundamentals
| Return On Equity | -0.0915 | ||||
| Return On Asset | 0.0097 | ||||
| Profit Margin | (0.01) % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 338.06 M | ||||
| Shares Outstanding | 102.83 M | ||||
| Shares Owned By Insiders | 2.52 % | ||||
| Shares Owned By Institutions | 60.93 % | ||||
| Number Of Shares Shorted | 4.19 M | ||||
| Price To Earning | 44.00 X | ||||
| Price To Book | 3.91 X | ||||
| Price To Sales | 0.39 X | ||||
| Revenue | 446.55 M | ||||
| Gross Profit | 144.09 M | ||||
| EBITDA | 5.71 M | ||||
| Net Income | (15.54 M) | ||||
| Cash And Equivalents | 97.84 M | ||||
| Cash Per Share | 1.05 X | ||||
| Total Debt | 210.75 M | ||||
| Debt To Equity | 3.90 % | ||||
| Current Ratio | 1.68 X | ||||
| Book Value Per Share | 0.47 X | ||||
| Cash Flow From Operations | (11.9 M) | ||||
| Short Ratio | 5.05 X | ||||
| Earnings Per Share | (0.04) X | ||||
| Price To Earnings To Growth | 0.08 X | ||||
| Target Price | 6.13 | ||||
| Number Of Employees | 987 | ||||
| Beta | 1.46 | ||||
| Market Capitalization | 178.93 M | ||||
| Total Asset | 468.63 M | ||||
| Retained Earnings | (517.68 M) | ||||
| Working Capital | 127.97 M | ||||
| Current Asset | 361.68 M | ||||
| Current Liabilities | 210.21 M | ||||
| Net Asset | 468.63 M |
About Accuray Incorporated Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Accuray Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accuray Incorporated using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accuray Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. Accuray Incorporated was incorporated in 1990 and is headquartered in Sunnyvale, California. Accuray operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 1044 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Accuray Stock Analysis
When running Accuray Incorporated's price analysis, check to measure Accuray Incorporated's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accuray Incorporated is operating at the current time. Most of Accuray Incorporated's value examination focuses on studying past and present price action to predict the probability of Accuray Incorporated's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accuray Incorporated's price. Additionally, you may evaluate how the addition of Accuray Incorporated to your portfolios can decrease your overall portfolio volatility.